| Target Price | $35.70 |
| Price | $16.52 |
| Potential |
116.10%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target Core Scientific 2027 .
The average Core Scientific target price is $35.70.
This is
116.10%
register free of charge
$57.75
249.58%
register free of charge
$24.34
47.34%
register free of charge
|
|
| A rating was issued by 26 analysts: 23 Analysts recommend Core Scientific to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Core Scientific stock has an average upside potential 2027 of
116.10%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 319.02 | 689.04 |
| 37.53% | 115.99% | |
| EBITDA Margin | -48.79% | 34.14% |
| 346.72% | 169.98% | |
| Net Margin | -88.00% | -48.82% |
| 63.91% | 44.52% |
20 Analysts have issued a sales forecast Core Scientific 2026 . The average Core Scientific sales estimate is
This results in the following potential growth metrics:
20 Analysts have issued an Core Scientific EBITDA forecast 2026. The average Core Scientific EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 Core Scientific Analysts have issued a net profit forecast 2026. The average Core Scientific net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.88 | -1.05 |
| 81.93% | 19.32% | |
| P/E | negative | |
| EV/Sales | 11.37 |
19 Analysts have issued a Core Scientific forecast for earnings per share. The average Core Scientific EPS is
This results in the following potential growth metrics and future valuations:
Core Scientific...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| Rothschild & Co |
Locked
➜
Locked
|
Locked | Sep 21 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Sep 17 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Keefe, Bruyette & Woods |
Locked
➜
Locked
|
Locked | Jul 30 2026 |
| Macquarie |
Locked
➜
Locked
|
Locked | Jul 29 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Jul 29 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
Rothschild & Co:
Locked
➜
Locked
|
Sep 21 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Sep 17 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Keefe, Bruyette & Woods:
Locked
➜
Locked
|
Jul 30 2026 |
|
Locked
Macquarie:
Locked
➜
Locked
|
Jul 29 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Jul 29 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


